buthionine sulfoximine has been researched along with Bone Diseases, Metabolic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, TJ; Davies, JT; Jagger, CJ; Lean, JM | 1 |
1 other study(ies) available for buthionine sulfoximine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants.
Topics: Animals; Antimetabolites; Antioxidants; Bone Diseases, Metabolic; Bone Resorption; Buthionine Sulfoximine; Estrogens; Glutathione; Mice; Mice, Inbred Strains; Mice, Knockout; Osteogenesis; Ovariectomy; Receptors, Tumor Necrosis Factor; Signal Transduction; Solubility; Sulfhydryl Compounds; Tumor Necrosis Factor-alpha | 2005 |